143 related articles for article (PubMed ID: 34636141)
1. The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells.
Panakkal V; Rana S; Rathore S; Anshu A; Balakrishnan A; Singh C; Jandial A; Sachdeva MUS; Varma N; Lad D; Malhotra P; Sreedharanunni S
Int J Lab Hematol; 2022 Feb; 44(1):157-162. PubMed ID: 34636141
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
[TBL] [Abstract][Full Text] [Related]
3. Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia.
Put N; Lemmens H; Wlodarska I; Konings P; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L
Genes Chromosomes Cancer; 2010 Nov; 49(11):991-7. PubMed ID: 20662075
[TBL] [Abstract][Full Text] [Related]
4. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
Cogbill CH; Spears MD; Vantuinen P; Harrington AM; Olteanu H; Kroft SH
Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
6. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
[TBL] [Abstract][Full Text] [Related]
7. Role of bone marrow imprints in haematological diagnosis: a detailed study of 3781 cases.
Gong X; Lu X; Wu X; Xu R; Tang Q; Xu G; Wang L; Zhang X; Zhao X
Cytopathology; 2012 Apr; 23(2):86-95. PubMed ID: 21129051
[TBL] [Abstract][Full Text] [Related]
8. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
[TBL] [Abstract][Full Text] [Related]
9. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment.
Pozdnyakova O; Crowley-Larsen P; Zota V; Wang SA; Miron PM
Cancer Genet Cytogenet; 2009 Mar; 189(2):112-7. PubMed ID: 19215792
[TBL] [Abstract][Full Text] [Related]
10. An Evaluation of a Fluorescence In Situ Hybridization Strategy Using Air-dried Blood and Bone-marrow Smears in the Risk Stratification of Pediatric B-Lineage Acute Lymphoblastic Leukemia in Resource-limited Settings.
Sharma P; Rana S; Sreedharanunni S; Gautam A; Sachdeva MUS; Naseem S; Varma N; Jain R; Bansal D; Trehan A
J Pediatr Hematol Oncol; 2021 May; 43(4):e481-e485. PubMed ID: 32769569
[TBL] [Abstract][Full Text] [Related]
11. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
12. Array-based karyotyping in plasma cell neoplasia after plasma cell enrichment increases detection of genomic aberrations.
Zehentner BK; Hartmann L; Johnson KR; Stephenson CF; Chapman DB; de Baca ME; Wells DA; Loken MR; Tirtorahardjo B; Gunn SR; Lim L
Am J Clin Pathol; 2012 Oct; 138(4):579-89. PubMed ID: 23010713
[TBL] [Abstract][Full Text] [Related]
13. [Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].
Li QZ; Tan K; Liu YX; Huang H; Zhang Y; Chen HM; Chen ZZ; Zhu ZW; Yang BH; Hu GY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1496-1500. PubMed ID: 36208255
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
Moore S; Suttle JM; Nicola M
Methods Mol Biol; 2017; 1541():127-142. PubMed ID: 27910020
[TBL] [Abstract][Full Text] [Related]
15. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
16. In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.
Debes Marun CS; Belch AR; Pilarski LM
Am J Hematol; 2012 Jun; 87(6):579-87. PubMed ID: 22495885
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
Ha J; Cho H; Lee TG; Shin S; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
Sci Rep; 2022 May; 12(1):8287. PubMed ID: 35585097
[TBL] [Abstract][Full Text] [Related]
18. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
19. [Influence of immunomagnetic sorting on detecting genetic aberration of multiple myeloma cells by interphase fluorescence in situ hybridization].
An G; Li CW; Li Q; Yi SH; Liu XP; Xu Y; Li ZJ; Qi JY; Zou DH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):54-8. PubMed ID: 21362221
[TBL] [Abstract][Full Text] [Related]
20. Implementation of cytogenomic microarray with plasma cell enrichment enables better abnormality detection and risk stratification in patients with plasma cell neoplasia than conventional cytogenetics and fluorescence in situ hybridization.
Chen C; Lim AST; Lau LC; Lim TH; Heng EYH; Tien SL
Cancer Genet; 2021 Apr; 252-253():25-36. PubMed ID: 33341677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
